These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4775860)

  • 21. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats.
    Zigmond MJ; Stricker EM
    Science; 1972 Sep; 177(4055):1211-4. PubMed ID: 5057630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changed eating and locomotor behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra.
    Brook C; Iversen SD
    Neuropharmacology; 1975 Feb; 14(2):95-105. PubMed ID: 1171387
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of intracisternal administration of prostaglandin E1 on waking and sleep in the rat.
    Masek K; Kadlecová O; Pöschlová N
    Neuropharmacology; 1976 Aug; 15(8):491-4. PubMed ID: 185541
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in fluid intake suggesting depressed appetite in rats with central catecholaminergic lesions.
    Sorensen CA; Ellison GD; Masuoka D
    Nat New Biol; 1972 Jun; 237(78):279-81. PubMed ID: 4556589
    [No Abstract]   [Full Text] [Related]  

  • 25. 6-Hydroxydopamine-induced blockade of hypothalamic obesity: critical role of brain dopamine-norepinephrine interaction.
    Coscina DV; Nobrega JN
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):369-72. PubMed ID: 6298885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 27. Central effects of 6-hydroxydopamine.
    De Carolis AS; Ziegler H; Del Basso P; Longo VG
    Physiol Behav; 1971 Nov; 7(5):705-8. PubMed ID: 5170825
    [No Abstract]   [Full Text] [Related]  

  • 28. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.
    Zigmond MJ; Stricker EM
    Experientia; 1980 Apr; 36(4):436-8. PubMed ID: 7379917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 30. Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain noradrenergic pathways.
    Ahlskog JE
    Physiol Behav; 1976 Sep; 17(3):407-11. PubMed ID: 1013186
    [No Abstract]   [Full Text] [Related]  

  • 31. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine release in the lateral hypothalamus is stimulated by α-MSH in both the anticipatory and consummatory phases of feeding.
    Legrand R; Lucas N; Breton J; Déchelotte P; Fetissov SO
    Psychoneuroendocrinology; 2015 Jun; 56():79-87. PubMed ID: 25805178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 6-hydroxydopamine, 5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats.
    Bläsig J; Reinhold K; Herz A
    Psychopharmacologia; 1973 Jul; 31(2):111-9. PubMed ID: 4578906
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 35. The failure of alpha-methyl-para-tyrosine to produce supersensitivity in 6-OHDA lesioned rats.
    Willis GL; Singer G
    Pharmacol Biochem Behav; 1980 Mar; 12(3):371-6. PubMed ID: 6248895
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone.
    Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP
    Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats.
    Phillips AG; Fibiger HC
    Behav Biol; 1976 Feb; 16(2):127-43. PubMed ID: 1259675
    [No Abstract]   [Full Text] [Related]  

  • 39. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats.
    Howard JL; Smith RD; Mueller RA; Breese GR
    Pharmacol Biochem Behav; 1974; 2(4):537-43. PubMed ID: 4153826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.